Abstract
The pathophysiology of brain injuries occurring due to neuroemergencies, such as stroke or head trauma, can be broadly classified into primary brain injury and secondary brain injury. The latter is a general term for brain damage caused by various pathologies that arise after the onset of injury and can be alleviated with treatment. Therefore, secondary brain injury is the primary therapeutic target in neurocritical care, and understanding its true nature is essential for neurocritical care physicians. In this section, I have explained the different pathologies that cause secondary brain injury and have commented on their relationships with current therapeutic options. The relation of systemic inflammation to neuroinflammation, a unique condition in the brain, has also been discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fitch MT, Doller C, Combs CK, Landreth GE, Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS. J Neurosci. 1999;19(19):8182–98.
Erickson MA, Dohi K, Banks WA. Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier. Neuroimmunomodulation. 2012;19(2):121–30.
Gadani SP, Walsh JT, Lukens JR, Kipnis J. Dealing with danger in the CNS: the response of the immune system to injury. Neuron. 2015;87(1):47–62.
Mizuma A, Yenari MA. Anti-inflammatory targets for the treatment of reperfusion injury in stroke. Front Neurol. 2017;8:467.
Hoogland IC, Houbolt C, van Westerloo DJ, van Gool WA, van de Beek D. Systemic inflammation and microglial activation: systematic review of animal experiments. J Neuroinflammation. 2015;6(12):114.
Thelin EP, Tajsic T, Zeiler FA, Menon DK, Hutchinson PJA, Carpenter KLH, Morganti-Kossmann MC, Helmy A. Monitoring the neuroinflammatory response following acute brain injury. Front Neurol. 2017;20(8):351.
Li WA, Moore-Langston S, Chakraborty T, Rafols JA, Conti AC, Ding Y. Hyperglycemia in stroke and possible treatments. Neurol Res. 2013;35(5):479–91.
Kinoshita K. Traumatic brain injury: pathophysiology for neurocritical care. J Intensive Care. 2016;4(29):27.
Shi J, Dong B, Mao Y, Guan W, Cao J, Zhu R, Wang S. Traumatic brain injury and hyperglycemia, a potentially modifiable risk factor. Oncotarget. 2016;7(43):71052–61.
Dohi K, Satoh K, Nakamachi T, Yofu S, Hiratsuka K, Nakamura S, Ohtaki H, Yoshikawa T, Shioda S, Aruga T. Does edaravone (MCI- 186) act as an antioxidant and a neuroprotector in experimental traumatic brain injury? Antioxid Redox Signal. 2007;9(2):281–7.
Dohi K, Jimbo H, Ikeda Y, Fujita S, Ohtaki H, Shioda S, Abe T, Aruga T. Pharmacological brain cooling with indomethacin in acute hemorrhagic stroke: antiinflammatory cytokines and antioxidative effects. Acta Neurochir Suppl. 2006;96:57–60.
Dohi K, Satoh K, Mihara Y, Nakamura S, Miyake Y, Ohtaki H, Nakamachi T, Yoshikawa T, Shioda S, Aruga T. Alkoxyl radical-scavenging activity of edaravone in patients with traumatic brain injury. J Neurotrauma. 2006;23(11):1591–9.
Dohi K, Ohtaki H, Nakamachi T, Yofu S, Satoh K, Miyamoto K, Song D, Tsunawaki S, Shioda S, Aruga T. Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury. J Neuroinflammation. 2010;7:41.
Dohi K, Kraemer BC, Erickson MA, McMillan PJ, Kovac A, Flachbartova Z, Hansen KM, Shah GN, Sheibani N, Salameh T, Banks WA. Molecular hydrogen in drinking water protects against neurodegenerative changes induced by traumatic brain injury. PLoS One. 2014;9(9):e108034.
Dohi K, Satoh K, Miyamoto K, Momma S, Fukuda K, Higuchi R, Ohtaki H, Banks WA. Molecular hydrogen in the treatment of acute and chronic neurological conditions: mechanisms of protection and routes of administration. J Clin Biochem Nutr. 2017;61(1):1–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Dohi, K. (2019). Pathology and Prevention of Secondary Brain Injury for Neurocritical Care Physicians. In: Kinoshita, K. (eds) Neurocritical Care . Springer, Singapore. https://doi.org/10.1007/978-981-13-7272-8_8
Download citation
DOI: https://doi.org/10.1007/978-981-13-7272-8_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7271-1
Online ISBN: 978-981-13-7272-8
eBook Packages: MedicineMedicine (R0)